HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

Published online before print July 6, 2005

This Article Full Text (Reprint (PDF)) All Versions of this Article: jlb.1004589v1 78/3/777    most recent Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Saito, H. Articles by Ogawa, J.-i. Search for Related Content PubMed PubMed Citation Articles by Saito, H. Articles by Ogawa, J.-i.

© by The Society for Leukocyte Biology
Journal of Leukocyte Biology, doi:10.1189/jlb.1004589

Received for publication October 15, 2004.
Revised December 20, 2004.
Accepted for publication May 24, 2005.

Article

Effect of antithrombin III on neutrophil deformability

Hajime Saito ^*@, Yoshihiro Minamiya ^*, Uwe Kalina , Satoshi Saito ^*, and Jun-ichi Ogawa ^*

*Department of Surgery, Division of Thoracic Surgery, Akita University School of Medicine, Akita City, Japan; and ZLB Behring, Marburg, Germany

^@ To whom correspondence should be addressed. E-mail: hsaito{at}doc.med.akita-u.ac.jp.

	Abstract

As the spherical diameter of pulmonary capillaries is smaller than that of neutrophils, increased neutrophil stiffness or conversely, decreased neutrophil deformability is a key step in the initial sequestration of neutrophils within the lungs during inflammatory processes. Antithrombin III (AT) is known to exert a therapeutic effect against disseminated intravascular coagulation, and accumulating evidence suggests that AT also has anti-inflammatory properties. The mechanisms of its anti-inflammatory effects remain unclear, but in a rat endotoxin model, AT apparently inhibited neutrophil sequestration in the lung. In the present in vitro study, therefore, we examined the effect of AT on the deformability of human neutrophils and correlated those findings with their F-actin content. Isolated human neutrophils were stimulated with formyl-Met-Leu-Phe (1 µM, 2 min) in the presence or absence of the , , or low heparin-affinity isoforms of AT (1 IU/ml, 20 min), and deformability was evaluated using a filter assay system. Neutrophils were also stained with fluorescein isothiocyanate-phalloidin and subjected to a fluorescein-activated cell sorter scan to assess F-actin content. The results showed that pretreatment with any of the three AT isoforms similarly inhibited the decreased neutrophil deformability and increased F-actin content of stimulated cells. Notably, heparinase had no effect on deformability or F-actin content in the presence or absence of AT, which was somewhat unexpected, as heparin sulfate proteoglycans likely function as AT receptors. These findings suggested that AT inhibits the increase in neutrophil stiffness seen during inflammatory processes by inhibiting actin polymerization via a heparin-independent pathway.

Key Words: F-actin • fMLP